Stockwire.com: MMR Information Systems, Inc. (OTCBB: FVRL) just released some important news.

Mar 04, 2009 (M2 PRESSWIRE via COMTEX) -- FVRL | Quote | Chart | News | PowerRating -- MMR Information Systems, Inc. (OTCBB: FVRL), just announced Drug Interaction Tool Offered Free in Response to Increasing At-Home Deaths From Medication Errors--564 Percent Increase in At-Home Medication Fatalities Cited.

A dedicated Chat Room for MMR, has been created at STOCKWIRE.com to discuss this news event.

Visit the following link to begin chatting with your fellow shareholders: http://www.stockwire.com/chat

----------------------------------------------------------

LOS ANGELES -- MMR Information Systems, Inc. (OTCBB: FVRL), which through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. (collectively, "MMR") provides consumer-controlled Personal Health Records ("PHRs") (www.mymedicalrecords.com) and electronic safe deposit box storage solutions (www.myesafedepositbox.com), announced that it is making its comprehensive Prescription Drug Database available for free at the MyMedicalRecords PHR site. Using the Cerner Multum(R) Drug Content Database, licensed to MMR from Cerner Corp. (Nasdaq: CERN), visitors can immediately check for potential adverse interactions across multiple prescription and over-the-counter drugs in a single step. The customized database includes detailed information on more than 20,000 drugs, with potential adverse reactions across all of them. The service is available at www.mymedicalrecords.com 24 hours a day, 7 days a week, from anywhere in the world on any Internet-connected device.

Last year's tragic death of Heath Ledger was widely cited in connection with the release of a study published by the Archives of Internal Medicine that found a 564 percent increase in at-home medication fatalities using prescription and over-the-counter drugs compared to 5 percent in the clinical setting. (The Institutes of Medicine has separately reported that over 1.5 million preventable drug-related injuries occur each year in hospital and clinical settings.) The 28-year-old actor, who was awarded the Oscar(R) for Supporting Actor for his role as the Joker in the "Dark Knight," died from an accidental prescription-drug overdose in his New York City apartment.

"As a company whose primary business is offering a low cost, easy-to-use Personal Health Record, we believe it is important to make tools available for consumers to educate themselves about the potential dangers of the prescription drugs they take in the ordinary course of their life," said Robert H. Lorsch, Chairman and CEO of MMR Information Systems, Inc. "Knowledge about what is in your medicine cabinet may be just as important as keeping family members, and particularly children, away from the neighborhood drug dealer."

According to David P. Phillips of the University of California at San Diego, the cited study's principal author, "The amount of medical supervision is going down and the amount of responsibility put on the patient's shoulders is going up."

The Prescription Drug Database tool lets visitors to www.mymedicalrecords.com learn important information about the drugs they take and adverse interactions, including with food. MyMedicalRecords PHR account-holders are also able to maintain an ongoing database of prescription and over-the-counter medications taken by up to 10 family members (including pets) in a secure online account.

About MMR Information Systems, Inc.

MMR Information Systems, Inc. (formerly Favrille, Inc.), through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. (collectively, "MMR"), provides secure and easy-to-use Web-based storage solutions, serving consumers, healthcare professionals, employers, insurance companies, unions and professional organizations. Seeking to empower consumers to have greater control over their health and well-being, MMR facilitates access to medical records and other important documents, such as living wills, birth certificates, passports, advance directives and insurance policies, anytime from anywhere using the Internet. MMR's principal product, the MyMedicalRecords PHR service, accessed through www.mymedicalrecords.com, is built on proprietary patent-pending technology that enables users to transmit documents, images and voicemail messages in and out of the MyMedicalRecords PHR system using a variety of methods, including fax, phone, and file upload without relying on any specific electronic medical record platform to populate a user's account. Users and medical providers can fax paper records (such as laboratory tests, radiology reports and physician's notes), or scanned images can be uploaded, into a secured personal account, which the user can access and organize as necessary, including filing particularly sensitive documents in virtual lockboxes protected by secondary passwords, and designating certain records as accessible to medical personnel and first responders by way of a separate Emergency Login. MMR also offers its MyEsafeDepositBox service, available at www.myesafedepositbox.com, which is designed to provide secure online storage for vital financial, legal and insurance documents in addition to medical records using the same patent-pending technologies that drive the MyMedicalRecords PHR service. In its final stages of development, MMR's MyMedicalRecords Pro service is designed to give physician's offices a cost-effective solution to the expensive and time-consuming problem of digitizing paper-based medical records. MMR clients include AFL-CIO, Alexian Brothers Hospital Network, Coverdell, MedicAlert, Midwest Research Institute, Qvisory, XN Financial and others. MMR is also one of the integrated service providers that launched on Google Health. Additional information regarding MMR's business and its products, including trial accounts, is available at www.mymedicalrecords.com and www.mmrinformationsystems.com. Information on MMR's Websites is not incorporated by reference into this press release.

----------------------------------------------------------

About Stockwire:

Stockwire is one of the largest communities for Micro Cap Investors. We are the only place on the internet to provide LIVE CHAT ROOMS for dedicated stocks.

We have also pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.

The Stockumentary has video interviews with management, product demos, video tours of office or factory, research reports, sec filings and much more. All of this is delivered to investors in high quality video, either by mail or email.

Stockwire.com is owned by Stockwire Research Group Inc. (SRGI) and is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies.

As detailed below, this publication accepts compensation from some of the companies from which it features. To the degrees listed herein, this Newsletter should not be regarded as an independent publication. All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the Newsletter is neither an offer nor solicitation to buy or sell any securities mentioned.

While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at www.sec.gov and/or the National Association of Securities Dealers ("NASD") at www.nasd.com. The NASD has published information on how to invest carefully at its web site.

Readers can review all public filings by companies at the SEC's EDGAR page. www.sec.gov/edgar.shtml

Stockwire.com is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. Stockwire.com is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.

From time to time SRGI sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.

Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features on Stockwire.com. To the degrees enumerated herein, this newsletter and website should not be regarded as an independent publication.

The editor, members of the editor's family, and/or entities with which the editor is affiliated aside from Stockwire Research Group Inc. (SRGI) itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE.COM.

We often accept restricted shares of company stock; by SEC regulations, restricted shares cannot be sold into the market for a period of at least one year from the time that the shares are issued. In such cases, we detail in the Disclaimer the specific term of any restrictions. We also receive compensation in the form of stock options, in which case we receive the right to buy shares of the stock of the company at issue, at a specified time and a specified price. In such circumstances, we specify on our Disclaimer the terms of the options received. On occasion, we also accept free-trading shares in a company that we cover. However, by policy we generally do not buy or sell any shares of a company's stock within three trading days after any such company's profile, commentary, or other company-specific information is disseminated on Stockwire.com Web site. In cases where we do trade within the three day window, our volume will never represent more than 5% of the daily volume, thereby minimizing any effect we could have on the potential price movement.

While our policies as detailed above are designed to minimize any impact upon our members of a conflict of interest between our company and our members, each member should be fully aware that such potential and actual conflicts of interest may well exist due to the compensation structure detailed herein. For this reason, and because the information contained on Stockwire.com is updated on a regular basis as circumstances change, each member is strongly encouraged to periodically review the Profile Compensation section at http://www.stockwire.com/disclaimer_profiles.htm.

CONTACT: The Stockwire Group Tel: +1 512 358 8440 e-mail: info@stockwire.com WWW: http://www.stockwire.com

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

More News:   Market Updates | Stock Alerts | All Trading News | Stock Index